医薬品坐薬市場：タイプ別（直腸坐薬、膣坐薬、尿道坐薬）、基剤別（脂肪性基剤、水混和性基剤、乳化性基剤）、流通チャネル別（病院薬局、小売薬局、オンライン販売）、エンドユーザー別（病院＆クリニック、在宅ケア、介護施設）：2027年の世界機会分析と産業予測

Pharmaceutical Suppositories Market by Type (Rectal Suppositories, Vaginal Suppositories, and Urethral Suppositories), Base (Fatty Base, Water Miscible Bases, and Emulsifying Bases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Sales), and End User (Hospitals & Clinics, Home Care, and Nursing Home): Global Opportunity Analysis and Industry Forecast, 2027

医薬品の坐薬市場は、坐薬として処方される医薬品の開発、生産、流通に関わる産業を指す。坐薬は固形または半固形の製剤で、局所的または全身的な薬物送達のために直腸、膣、尿道に挿入される。坐薬には、特... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
IHR Insights アイエイチアールインサイト	2023年7月7日	US$4,500 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	268	英語

目次
図表リスト

サマリー

医薬品の坐薬市場は、坐薬として処方される医薬品の開発、生産、流通に関わる産業を指す。坐薬は固形または半固形の製剤で、局所的または全身的な薬物送達のために直腸、膣、尿道に挿入される。

坐薬には、特定の解剖学的部位への局所的な薬物送達、消化管のバイパス、胃酸や肝臓での代謝による分解のリスクを低減した全身吸収など、いくつかの利点がある。胃腸障害、疼痛管理、ホルモン療法、特定の感染症など、さまざまな治療分野で使用されている。医薬用坐薬市場は2027年までに5.9%CAGRで成長する見込み

医薬品用坐薬市場：タイプ別

直腸用坐剤
膣坐剤
尿道坐剤

医薬品坐剤市場：ベース別

脂肪性基剤
水混和性基剤
乳化性ベース

医薬品坐剤市場エンドユーザー別

病院・クリニック
在宅介護
介護施設

医薬品坐薬市場地域別

北米
欧州
アジア太平洋
その他の地域

タイプ別市場としては、直腸坐薬、膣坐薬、尿道坐薬に分別される。直腸坐薬は医薬品坐薬市場の成長において最も高い収益を生み出した。これは直腸坐薬の開発に注目が集まっているためである。

基剤ベースでは、水混和性基剤（石鹸グリセリン坐剤、ポリエチレングリコール基剤、グリセロゼラチン基剤）、脂肪性基剤、乳化性基剤（マサエステリウム、ウィテプゾール、マスポール）に区分される。乳化性ベースはベース分野で最大のシェアを占めている。乳化性ベースは素早く固まり、刺激がなく、腐敗しにくいからである。

医薬品座薬市場は、エンドユーザー別に病院・診療所、介護施設、在宅介護に区分される。このうち、病院・診療所セグメントは市場で最も高い収益をあげている。これは、小児や高齢の患者を即座に治療するために、病院が医薬品座薬に傾倒しているためである。

坐薬には、特定の解剖学的部位への局所的な薬物送達、消化管のバイパス、胃酸や肝臓代謝による分解リスクを低減した全身吸収など、いくつかの利点がある。胃腸障害、疼痛管理、ホルモン療法、特定の感染症など、さまざまな治療分野で使用されている。

医薬品坐剤市場の主な側面は以下の通り：

坐薬の種類

直腸坐剤：これらの坐薬は直腸に挿入され、局所的または全身的な薬物送達に一般的に使用される。便秘、痔核、炎症性腸疾患、および全身性の疾患に対する薬剤を送達することができる。

腟坐剤：膣坐薬は膣に挿入し、膣感染症、ホルモン療法、避妊などの症状の局所治療に使用される。

尿道坐剤：尿道坐薬は尿道に挿入し、主に勃起不全などの症状の治療に使用される。

市場の大手企業は、Bayer Ag、Bliss Gvs Pharma Ltd、Cadila Healthcare Ltd、Church And Dwight Uk Ltd、Cosette Pharmaceuticals, Inc、Glenmark Pharmaceuticals Limited、Intas Pharmaceuticals Ltd、Novartis International Ag、Pfizer Inc、Sanofi S.A.である。

治療用途

胃腸障害：坐薬は、便秘、痔、炎症性腸疾患などの症状に対する薬物送達に使用され、局所的な緩和や全身的な薬物吸収をもたらす。

疼痛管理：坐薬には鎮痛薬や抗炎症薬を配合することができ、術後痛のための直腸坐薬や月経痛のための膣坐薬など、局所的な痛みを緩和する。

ホルモン療法：ホルモン補充療法、避妊、または更年期障害や子宮内膜症などの疾患の治療のために、坐薬を通してホルモンを投与することができる。

感染症：膣や直腸の感染症の局所治療のために、坐薬で抗菌薬を投与することができる。

市場の推進要因：

治療効果を向上させる代替ドラッグデリバリーシステムに対する需要の高まり。胃腸障害と疼痛関連疾患の有病率の増加が市場成長を促進している。

放出制御や薬物バイオアベイラビリティの向上など、坐薬処方技術の進歩。

本レポートは、地域内の製品/サービスの消費という観点から地理的なハイライトを分析し、各地域内の医薬品坐薬市場に影響を与えている要因も示しています。
医薬品用坐薬の世界市場におけるプレーヤーが直面する機会と課題について掲載しています。
本レポートは、最も速い成長を目撃すると予測される地理的およびセグメント的分析を示唆しています。

新製品発売、提携、事業拡大、買収と相まって、主要企業の市場ランキングを含む競争展望を提供します。

ページTOPに戻る

1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Type: Market Size & Analysis
5.1. Rectal Suppositories
5.2. Vaginal Suppositories
5.3. Urethral Suppositories
6. BASE: Market Size & Analysis
6.1. Fatty Bases
6.2. Water Miscible Base
6.3. Emulsifying Bases
7. Distribution Channel: Market Size & Analysis
7.1. Hospital Pharmacies
7.2. Retail Pharmacies
7.3. Online Sales
8. END USER: Market Size & Analysis
8.1. Hospitals & Clinics
8.2. Home Care
8.3. Nursing Home
9. Geography: Market Size & Analysis
9.1. Overview
9.2. North America
9.3. Europe
9.4. Asia Pacific
9.5. Rest of the World
10. Competitive Landscape
10.1. Competitor Comparison Analysis
10.2. Market Developments
10.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
10.2.2. Product Launches and execution
11. Vendor Profiles
11.1. .Bayer Ag,
11.1.1. Overview
11.1.2. Financial Overview
11.1.3. Product Offerings
11.1.4. Developments
11.1.5. Business Strategy
11.2. Bliss Gvs Pharma Ltd
11.2.1. Overview
11.2.2. Financial Overview
11.2.3. Product Offerings
11.2.4. Developments
11.2.5. Business Strategy
11.3. Cadila Healthcare Ltd.
11.3.1. Overview
11.3.2. Financial Overview
11.3.3. Product Offerings
11.3.4. Developments
11.3.5. Business Strategy
11.4. Church And Dwight Uk Ltd,
11.4.1. Overview
11.4.2. Financial Overview
11.4.3. Product Offerings
11.4.4. Developments
11.4.5. Business Strategy
11.5. Cosette Pharmaceuticals, Inc
11.5.1. Overview
11.5.2. Financial Overview
11.5.3. Product Offerings
11.5.4. Developments
11.5.5. Business Strategy
11.6. Glenmark Pharmaceuticals Limited
11.6.1. Overview
11.6.2. Financial Overview
11.6.3. Product Offerings
11.6.4. Developments
11.6.5. Business Strategy
11.7. Intas Pharmaceuticals Ltd,
11.7.1. Overview
11.7.2. Financial Overview
11.7.3. Product Offerings
11.7.4. Developments
11.7.5. Business Strategy
11.8. Pfizer Inc.,.
11.8.1. Overview
11.8.2. Financial Overview
11.8.3. Product Offerings
11.8.4. Developments
11.8.5. Business Strategy
11.9. Novartis International Ag.
11.9.1. Overview
11.9.2. Financial Overview
11.9.3. Product Offerings
11.9.4. Developments
11.9.5. Business Strategy
11.10. Sanofi S.A
11.10.1. Overview
11.10.2. Financial Overview
11.10.3. Product Offerings
11.10.4. Developments
11.10.5. Business Strategy
12. Analyst Opinion
13. Annexure
13.1. Report Scope
13.2. Market Definitions
13.3. Research Methodology
13.3.1. Data Collation and In-house Estimation
13.3.2. Market Triangulation
13.3.3. Forecasting
13.4. Report Assumptions
13.5. Declarations
13.6. Stakeholders
13.7. Abbreviations

ページTOPに戻る

図表リスト

TABLE 1. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 2. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR RECTAL SUPPOSITORIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR VAGINAL SUPPOSITORIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR URETHRAL SUPPOSITORIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR FATTY BASES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 7. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR WATER MISCIBLE BASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR EMULSIFYING BASES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR HOSPITAL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR RETAIL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 12. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR ONLINE SALES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 13. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER CHANNEL, 2021-2027 (USD BILLION)
TABLE 14. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR HOSPITALS & CLINICS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 15. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR HOME CARE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 16. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR NURSING HOME, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 17. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 18. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 19. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 20. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL,2021-2027 (USD BILLION)
TABLE 21. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 22. U.SPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 23. U.SPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 24. U.SPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL,2021-2027 (USD BILLION)
TABLE 25. U.S PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 26. CANADAPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 27. CANADAPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 28. CANADAPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 29. CANADAPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER ,2021-2027 (USD BILLION)
TABLE 30. EUROPEPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 31. EUROPEPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 32. EUROPEPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 33. EUROPEPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, DISTRIBUTION CHANNEL,2021-2027 (USD BILLION)
TABLE 34. EUROPEPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, END USER,2021-2027 (USD BILLION)
TABLE 35. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BYTYPE, 2021-2027 (USD BILLION)
TABLE 36. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET VALUEBY BASE, 2021-2027 (USD BILLION)
TABLE 37. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 38. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 39. U.K PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 40. U.K PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 41. U.K PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 42. U.K PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 43. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 44. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 45. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 46. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 47. ITALY PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 48. ITALY PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 49. ITALY PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 50. ITALY PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 51. SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 52. SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 53. SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL,2021-2027 (USD BILLION)
TABLE 54. SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER,2021-2027 (USD BILLION)
TABLE 55. ROE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE,2021-2027 (USD BILLION)
TABLE 56. ROE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 57. ROE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 58. ROE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY ENS USER, 2021-2027 (USD BILLION)
TABLE 59. ASIA PACIFC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 60. ASIA PACIFC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 61. ASIA PACIFC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 62. ASIA PACIFC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 63. ASIA PACIFC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 64. CHINA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 65. CHINA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 66. CHINA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 67. CHINA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 68. INDIA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 69. INDIA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 70. INDIA HERPES ZOSTER TREATMETMARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 71. INDIA HERPES ZOSTER TREATMETMARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 72. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE2021-2027 (USD BILLION)
TABLE 73. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 74. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 75. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 76. REST OF APAC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 77. REST OF APAC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 78. REST OF APAC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 79. REST OF APAC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 80. REST OF WORLD PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 81. REST OF WORLD PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 82. REST OF WORLD PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 83. REST OF WORLD PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 84. BAYER AG: FINANCIALS
TABLE 85. BAYER AG: PRODUCTS & SERVICES
TABLE 86. BAYER AG: RECENT DEVELOPMENTS
TABLE 87. BLISS GVS PHARMA LTD: FINANCIALS
TABLE 88. BLISS GVS PHARMA LTD: PRODUCTS & SERVICES
TABLE 89. BLISS GVS PHARMA LTD: RECENT DEVELOPMENTS
TABLE 90. CADILA HEALTHCARE LTD: FINANCIALS
TABLE 91. CADILA HEALTHCARE LTD: PRODUCTS & SERVICES
TABLE 92. CADILA HEALTHCARE LTD: RECENT DEVELOPMENTS
TABLE 93. CHURCH AND DWIGHT UK LTD: FINANCIALS
TABLE 94. CHURCH AND DWIGHT UK LTD: PRODUCTS & SERVICES
TABLE 95. CHURCH AND DWIGHT UK LTD: RECENT DEVELOPMENTS
TABLE 96. COSETTE PHARMACEUTICALS, INC: FINANCIALS
TABLE 97. COSETTE PHARMACEUTICALS, INC.: PRODUCTS & SERVICES
TABLE 98. COSETTE PHARMACEUTICALS, INC..: RECENT DEVELOPMENTS
TABLE 99. GLENMARK PHARMACEUTICALS LIMITED: FINANCIALS
TABLE 100. GLENMARK PHARMACEUTICALS LIMITED: PRODUCTS & SERVICES
TABLE 101. GLENMARK PHARMACEUTICALS LIMITED: RECENT DEVELOPMENTS
TABLE 102. NOVARTIS AG: FINANCIALS
TABLE 103. NOVARTIS AG: PRODUCTS & SERVICES
TABLE 104. NOVARTIS AG: RECENT DEVELOPMENTS
TABLE 105. PFIZER INC: FINANCIALS
TABLE 106. PFIZER INC: PRODUCTS & SERVICES
TABLE 107. PFIZER INC: RECENT DEVELOPMENTS
TABLE 108. INTAS PHARMACEUTICALS LTD.: FINANCIALS
TABLE 109. INTAS PHARMACEUTICALS LTD.: PRODUCTS & SERVICES
TABLE 110. INTAS PHARMACEUTICALS LTD.: RECENT DEVELOPMENTS
TABLE 111. SANOFI S.A: FINANCIALS
TABLE 112. SANOFI S.A: PRODUCTS & SERVICES
TABLE 113. SANOFI S.A: RECENT DEVELOPMENTS

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

The pharmaceutical suppositories market refers to the industry involved in the development, production, and distribution of medications that are formulated as suppositories. Suppositories are solid or semisolid formulations that are inserted into the rectum, vagina, or urethra for local or systemic drug delivery.

Pharmaceutical suppositories offer several advantages, including localized drug delivery to specific anatomical sites, bypassing the gastrointestinal tract, and providing systemic absorption with a reduced risk of degradation by stomach acids or liver metabolism. They are used in various therapeutic areas, including gastrointestinal disorders, pain management, hormonal therapy, and certain infectious diseases. Pharmaceutical Suppositories Market is likely to grow at a rate of 5.9%CAGR by 2027

Pharmaceutical suppositories market By Type

Rectal Suppositories
Vaginal Suppositories
Urethral Suppositories

Pharmaceutical suppositories market By Base

Fatty Bases
Water Miscible Base
Emulsifying Bases

Pharmaceutical suppositories market By End User

Hospitals & Clinics
Home Care
Nursing Home

Pharmaceutical suppositories market By Region

North America
Europe
Asia Pacific
Rest of the World

As in the market by type is segregated into rectal suppositories, vaginal suppositories and urethral suppositories. The rectal suppository generated the highest revenue in the Pharmaceutical suppositories market growth. This can be ascribed to the rise in focus on the development of rectal suppository.

On the basis of base, the segmentation is classified as the water-miscible base (soap glycerin suppositories, polyethylene glycol bases, and glycero gelatin base), fatty bases, and emulsifying bases (Massa esterium, witepsol, and massuppol). The emulsifying bases have leaded the base segment with maximum share. Since, emulsifying bases solidify quickly, are nonirritant, and are less liable to get rancid.

On the basis of end-user segment the pharmaceutical suppositories market is segmented into hospitals & clinics, nursing homes, and home care. Where, the hospitals & clinics segment has observed the highest revenue in the market. This is because of the rising inclination of hospitals towards pharmaceutical suppositories to instantly treat pediatric or old patients.

Pharmaceutical suppositories offer several advantages, including localized drug delivery to specific anatomical sites, bypassing the gastrointestinal tract, and providing systemic absorption with a reduced risk of degradation by stomach acids or liver metabolism. They are used in various therapeutic areas, including gastrointestinal disorders, pain management, hormonal therapy, and certain infectious diseases.

Key aspects of the pharmaceutical suppositories market include:

Types of Suppositories:

Rectal Suppositories: These suppositories are inserted into the rectum and are commonly used for local or systemic drug delivery. They can deliver medications for constipation, hemorrhoids, inflammatory bowel disease, and systemic conditions.

Vaginal Suppositories: Vaginal suppositories are inserted into the vagina and are used for local treatment of conditions such as vaginal infections, hormonal therapy, and contraception.

Urethral Suppositories: Urethral suppositories are inserted into the urethra and are primarily used for the treatment of conditions like erectile dysfunction.

The leading players of the market are Bayer Ag, Bliss Gvs Pharma Ltd, Cadila Healthcare Ltd, Church And Dwight Uk Ltd, Cosette Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Novartis International Ag, Pfizer Inc., and Sanofi S.A.

Therapeutic Applications:

Gastrointestinal Disorders: Suppositories are used to deliver medications for conditions like constipation, hemorrhoids, and inflammatory bowel disease, providing local relief or systemic drug absorption.

Pain Management: Suppositories can be formulated with analgesics or anti-inflammatory drugs for localized pain relief, such as rectal suppositories for postoperative pain or vaginal suppositories for menstrual pain.

Hormonal Therapy: Hormones can be delivered through suppositories for hormonal replacement therapy, contraception, or treatment of conditions like menopause or endometriosis.

Infectious Diseases: Suppositories can deliver antimicrobial medications for local treatment of vaginal or rectal infections.

Market Drivers:

Increasing demand for alternative drug delivery systems with improved therapeutic outcomes. Growing prevalence of gastrointestinal disorders and pain-related conditions are propelling the market growth.

Advancements in suppository formulation techniques, including controlled release and enhanced drug bioavailability.

The report analyzes the geographical highlights in terms of consumption of the product/service within the region also indicates the factors which are affecting the pharmaceutical suppositories market within each region.
The report comprises of opportunities and challenges faced by the players in the global pharmaceutical suppositories
The report implies the geographical and segmental analysis which is anticipated to witness the fastest growth.

Provides competitive outlook which includes the market ranking of the key players, coupled with new product launches, partnerships, business expansions, and acquisition.

ページTOPに戻る

List of Tables/Graphs

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（通信回線）の最新刊レポート

IHR Insights 社の最新刊レポート

本レポートと同じKEY WORD（channel）の最新刊レポート

よくあるご質問

IHR Insights社はどのような調査会社ですか?

IHR InsightsはICT、化学品、ヘルスケア、半導体など、世界の幅広い分野を対象に調査し、専門的な知識を基に市場調査報告書を出版しています。主な調査分野 ◇ICT ◇化学品、材料、... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（通信回線）の最新刊レポート

IHR Insights 社の最新刊レポート

本レポートと同じKEY WORD（channel）の最新刊レポート

よくあるご質問

IHR Insights社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?